EMBL: Trapped in a ring
Heidelberg (D) | Ring-like protein complex helps ensure accurate protein production

Medictye: Medicyte Announces New Website
Heidelberg (D) | The life science company Medicyte, specialised in standardising primary cell products, launched its new website www.medicyte.com including shop-function with a dynamic, new look.

SYGNIS announces nine months results of fiscal year 2011/2012
Heidelberg, February 14, 2012 – SYGNIS Pharma AG (Frankfurt: LIOK; ISIN DE000A1E9B74; Prime Standard) today reports its financial results for the third quarter and the first nine months of the fiscal year 2011/2012 ended December...

DKFZ: Stress in cells activates hepatitis viruses
Substances which suppress the immune system while simultaneously keeping viral infections in check would be an ideal drug for organ transplant recipients. Scientists of the German Cancer Research Center (Deutsches...

Merck: Merck and Threshold Announce Global Agreement to Co-Develop and Commercialize Phase III Hypoxia-Targeted Drug TH-302
Darmstadt (D) | Phase III soft tissue sarcoma trial ongoing; randomized Phase II pancreatic cancer trial expected to report in February 2012. Deal provides Threshold with an upfront payment of € 19 million ($ 25 million), plus...

Phone: +49 6221 - 64 922 0
Fax: +49 6221 - 64 922 15
Email: info@bioregion-rnd.de